Guardant Health, Inc.
Develops liquid biopsies for cancer detection, monitoring, and personalized treatment guidance.
GH | NDAQ
Overview
Corporate Details
- ISIN(s):
- US40131M1099
- LEI:
- Country:
- United States of America
- Address:
- 3100 HANOVER STREET, 94304 PALO ALTO
- Website:
- https://guardanthealth.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Guardant Health, Inc. is a precision oncology company dedicated to transforming cancer care through data. The company develops and commercializes advanced blood tests, known as liquid biopsies, which analyze circulating tumor DNA to provide critical insights for oncologists and patients. These non-invasive tests are designed to be used across the entire cancer care continuum, from early-stage cancer detection and residual disease monitoring to guiding personalized treatment decisions for patients with advanced cancer. By leveraging its data-driven platform, Guardant Health aims to improve clinical outcomes and help patients live longer, healthier lives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Guardant Health, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Guardant Health, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Guardant Health, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
